about
Humanin, a cytoprotective peptide, is expressed in carotid atherosclerotic [corrected] plaques in humansGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Humanin preserves endothelial function and prevents atherosclerotic plaque progression in hypercholesterolemic ApoE deficient miceHumanin is expressed in human vascular walls and has a cytoprotective effect against oxidized LDL-induced oxidative stressParadigm Shifts in Atherosclerotic Renovascular Disease: Where Are We Now?Renal relevant radiology: renal functional magnetic resonance imagingNew magnetic resonance imaging methods in nephrologyClinical implications of intracoronary imaging in cardiac allograft vasculopathyGained in translation: protective paradigms for the poststenotic kidneyDarkness at the end of the tunnel: poststenotic kidney injuryInvestigating the Metabolic Syndrome: Contributions of Swine ModelsConcurrent treatment with renin-angiotensin system blockers and acetylsalicylic acid reduces nuclear factor kappaB activation and C-reactive protein expression in human carotid artery plaquesAntiphospholipid Syndrome: Role of Vascular Endothelial Cells and Implications for Risk Stratification and Targeted Therapeutics.Noninvasive Assessment of Renal Fibrosis with Magnetization Transfer MR Imaging: Validation and Evaluation in Murine Renal Artery StenosisMagnetic resonance elastography noninvasively detects in vivo renal medullary fibrosis secondary to swine renal artery stenosisAntioxidants improve early survival of cardiomyoblasts after transplantation to the myocardium.Phase-contrast MRI-based elastography technique detects early hypertensive changes in ex vivo porcine aortic wall.Noninvasive measurement of concurrent single-kidney perfusion, glomerular filtration, and tubular function.Physical training and metabolic supplementation reduce spontaneous atherosclerotic plaque rupture and prolong survival in hypercholesterolemic mice.Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering.Hypercholesterolemia impairs myocardial perfusion and permeability: role of oxidative stress and endogenous scavenging activity.Increased oxidative stress in experimental renovascular hypertension.Combination of hypercholesterolemia and hypertension augments renal function abnormalities.c-myc activation in early coronary lesions in experimental hypercholesterolemia.Beneficial effects of concurrent autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the mouse hindlimbTherapeutic effects of concurrent autologous bone marrow cell infusion and metabolic intervention in ischemia-induced angiogenesis in the hypercholesterolemic mouse hindlimb.Autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the diabetic mouse hindlimb.Therapeutic effects of autologous bone marrow cells and metabolic intervention in the ischemic hindlimb of spontaneously hypertensive rats involve reduced cell senescence and CXCR4/Akt/eNOS pathways.Workplace Digital Health Is Associated with Improved Cardiovascular Risk Factors in a Frequency-Dependent Fashion: A Large Prospective Observational Cohort Study.Digital health intervention during cardiac rehabilitation: A randomized controlled trial.On to the road to degradation: atherosclerosis and the proteasomeAnti-thrombin therapy during warm ischemia and cold preservation prevents chronic kidney graft fibrosis in a DCD model.Extrarenal atherosclerotic disease blunts renal recovery in patients with renovascular hypertension.Single nucleotide polymorphisms associated with abnormal coronary microvascular function.Cardiac production of angiotensin II and its pharmacologic inhibition: effects on the coronary circulation.Valsartan regulates myocardial autophagy and mitochondrial turnover in experimental hypertensionNovel functional risk factors for the prediction of cardiovascular events in vulnerable patients following acute coronary syndrome.Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham scoreCoronary endothelial function in patients with obstructive sleep apnea.Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis.
P50
Q21134790-689CD7C9-39CB-4D60-820A-D70BCC94F2C1Q22676705-05E9E618-C84D-4A0C-8EDD-251B4F2FC39FQ24620070-753DEBA4-2882-4CA6-AF74-265844C45D6DQ24633354-9C6CEEA5-00DF-4833-B04F-3E11D6DB4416Q26828388-67356055-3BF1-4382-836C-C4297081DC2AQ26853154-7EB74524-E19B-40BB-8311-AD294437E97AQ26866166-467D418F-E288-4FE0-AB41-989EB8F3DB7FQ26866287-C851EB4D-7399-4F0B-B64E-65BB04BF559BQ27011613-A24483F5-DC16-4937-82A3-5C467CEF6B80Q27014398-0C5627E2-3434-4A5B-B57B-B7AA2158B80EQ28069653-4BC4E925-F8AC-4096-8F0D-538B6CC16B63Q28211061-5CFE7A3D-70F5-4451-8660-E5FA8825A3A5Q30234565-4D5CF6CD-12E9-43CD-AD95-0353BF60D367Q30360025-218068A4-1951-4BEA-A320-28147E155518Q30443567-A5216FDB-43CC-4969-8282-52330698D752Q30475341-82E0ABF3-970F-4542-8B2F-90962BDA8EA3Q30478813-08D5CD65-EC8E-4A39-8154-3DDC41D91C4FQ31009324-275B5963-77AD-4680-A4AA-B3BB2EF7CDFFQ31046745-675B9461-03DD-49C8-9EBA-5BFE447DEDE5Q31807283-A8F7E876-997F-4F50-94DE-60032D1156C6Q32055157-81B52D1C-3E8D-4320-A3DF-22A9C620C60CQ32071899-14802C3F-1FBF-4724-B02D-D64D0AE6B181Q32073018-235AEB80-00EF-4164-8DB6-874D8D7CD994Q32126675-46BE9EE7-2465-443F-8948-5A1352BCB878Q33227147-ADAD5192-6B04-4F3D-8337-63AB9991FA0CQ33252182-ED7EABCD-87DA-4675-8A96-432CB796ACCEQ33266766-2957501D-02BA-4B79-B063-2AF52A7E9A83Q33307935-4414518B-F5F3-4AF7-87AC-B16A02E5786DQ33448327-358D2ABA-7CE8-4C5D-83AE-04B4E79ABB9AQ33454821-3A696DE7-ED4E-44CF-8EA3-FFF45E77CDAEQ33554513-2F14170E-59F6-44D3-8EAE-56646465C171Q33593163-D469DE2E-C350-473D-9F57-E05D600F5A94Q33594507-D5188F09-6F4E-4DD8-8C8C-D7C9935FD698Q33596941-8C56CA89-CB64-48AE-B9D2-E11F97125096Q33630460-87F217AD-25B0-4A45-92A5-91CA1892D250Q33754050-E2878A36-46C1-4253-8721-D258EF235988Q33781277-F483C141-69F3-425E-82B3-A8623A983F9BQ33788911-CF74EC0A-21CA-47B4-B1DE-FC88030A3EE9Q33815095-0D76A989-90C3-4015-8F4B-FCB06683BC16Q33834701-DE53E616-172A-45A4-8B1F-DE96242108DC
P50
name
Lilach O. Lerman
@en
Lilach O. Lerman
@es
Lilach O. Lerman
@nl
type
label
Lilach O. Lerman
@en
Lilach O. Lerman
@es
Lilach O. Lerman
@nl
altLabel
L Lerman
@en
L O Lerman
@en
L. Lerman
@en
L. O. Lerman
@en
Lerman L
@en
Lerman L. O.
@en
Lerman L.
@en
Lerman LO
@en
Lerman
@en
Lilach Lerman
@en
prefLabel
Lilach O. Lerman
@en
Lilach O. Lerman
@es
Lilach O. Lerman
@nl